CSMLSM
Senior Member
- Messages
- 973
@mariovitali impressive work, thorough.
It is a selective CB2 agonist.
I also use CBD.
Here is an abstract of a paper that links things we are both doing/targeting.
I knew I remembered something relating to your ER stress theory.
I have fragmented/deteriorated memory from many bouts of severe B12 deficiency so my past research is problematic to access and at the time notes were not possible due to how ill I was.
https://pubmed.ncbi.nlm.nih.gov/36374961/
Turmeric contains caryophyllene which is the target component of the copaiba essential oil I use.ER Stress support : TUDCA, Curcumin (i either use turmeric powder sprinkled in salads or use Mustard). Some olive oil is used for better absorption.
It is a selective CB2 agonist.
I also use CBD.
Here is an abstract of a paper that links things we are both doing/targeting.
I knew I remembered something relating to your ER stress theory.
I have fragmented/deteriorated memory from many bouts of severe B12 deficiency so my past research is problematic to access and at the time notes were not possible due to how ill I was.
https://pubmed.ncbi.nlm.nih.gov/36374961/
Promising Action of Cannabinoids on ER Stress-Mediated Neurodegeneration: An In Silico Investigation
Fathima Hajee Basha 1, Mohammad Waseem 1, Hemalatha Srinivasan 1
Affiliations expand
- PMID: 36374961
- DOI: 10.1615/JEnvironPatholToxicolOncol.2022040055
Abstract
Neurodegeneration has been recognized as a clinical episode characterized by neuronal death, including dementia, cognitive impairment and movement disorder. Most of the neurodegenerative deficits, via clinical symptoms, includes common pathogenic features as protein misfolding and aggregation. Therefore, the focus highlights the cellular organelle endoplasmic reticulum (ER) critically linked with the quality control and protein homeostasis. Unfolded protein response (UPR) or ER stress have also been considered as hallmarks for neurodegenerative disorders. It has been implicated that the levels of endocannabinoids (ECB) could rise at the platform of neurodegeneration. In addition, phytocannabinoids (PCB) including cannabidiol (CBD) could also initiate the IRE1, PERK, XBP-1, and ATF6, pathways that could lead to the degradation of the misfolded proteins and termination of protein translation. Thus, our aim was to determine if cannabinoids bind to these ER arm proteins involved in UPR by molecular docking and therefore determine its drug resemblance through ADME analysis. In our study, three cannabinoid receptors (CB1, CB2, and CB3) were considered to demonstrate their neuroprotective actions. The chosen ligands were screened as PCB (Δ9-tetrahydrocannabinol or THC), CBD, and two ECB, anandamide (AEA) and 2-arachidonoylglycerol (2-AG). The current findings have advocated that the cannabinoids and their molecular targets have shown considerable binding and their ADME properties also reveals that they possess moderate drug-like properties making it as a valuable option for the treatment and management of neurodegenerative diseases.